Scholarlink

<p>Tongue squamous cell carcinoma (TSCC) is an aggressive malignancy with a poor prognosis. The miR-302 family of microRNAs regulates stemness and differentiation, but its role in TSCC remains unknown. Here, we report that miR-372-3p, miR-302c-3p, and miR-520a-3p function as potent tumor suppressors in TSCC. These miRNAs inhibited cell proliferation, clonogenic growth, and induced apoptosis in vitro and in vivo. Transcriptomic analysis revealed that miR-302 overexpression silences pro-survival and inflammatory pathways. We found that these miRNAs directly target the NF-κB subunit P65 (RELA), which is upregulated in TSCC. Knockdown of P65 recapitulated the tumor-suppressive effects of miR-302, whereas P65 reconstitution partially rescued apoptosis and growth inhibition caused by miR-302. Both P65 knockdown and miR-302 overexpression dramatically slowed tumor growth in vivo. Our results demonstrate the therapeutic potential of a novel miR-302/P65 axis that limited the progression of TSCC by regulating apoptosis and oncogenic transcription.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The miR-302 family suppresses tumor growth in tongue squamous cell carcinoma by directly targeting P65

  • 期刊论文

  • 发表日期：

    2026年6月21日

查看全文
  • Liping Zhang,
  • Kejie Chang,
  • Lele Niu,
  • Xiansheng Zhao,
  • Quyang Yang,
  • Tao Zhang,
  • Wei-Qiang Tan,
  • Ningwen Zhu

摘要

Tongue squamous cell carcinoma (TSCC) is an aggressive malignancy with a poor prognosis. The miR-302 family of microRNAs regulates stemness and differentiation, but its role in TSCC remains unknown. Here, we report that miR-372-3p, miR-302c-3p, and miR-520a-3p function as potent tumor suppressors in TSCC. These miRNAs inhibited cell proliferation, clonogenic growth, and induced apoptosis in vitro and in vivo. Transcriptomic analysis revealed that miR-302 overexpression silences pro-survival and inflammatory pathways. We found that these miRNAs directly target the NF-κB subunit P65 (RELA), which is upregulated in TSCC. Knockdown of P65 recapitulated the tumor-suppressive effects of miR-302, whereas P65 reconstitution partially rescued apoptosis and growth inhibition caused by miR-302. Both P65 knockdown and miR-302 overexpression dramatically slowed tumor growth in vivo. Our results demonstrate the therapeutic potential of a novel miR-302/P65 axis that limited the progression of TSCC by regulating apoptosis and oncogenic transcription.